2014
DOI: 10.1089/scd.2013.0477
|View full text |Cite
|
Sign up to set email alerts
|

Functional Comparison of Human-Induced Pluripotent Stem Cell-Derived Mesenchymal Cells and Bone Marrow-Derived Mesenchymal Stromal Cells from the Same Donor

Abstract: Mesenchymal stem cells (MSCs) have a high potential for therapeutic efficacy in treating diverse musculoskeletal injuries and cardiovascular diseases, and for ameliorating the severity of graft-versus-host and autoimmune diseases. While most of these clinical applications require substantial cell quantities, the number of MSCs that can be obtained initially from a single donor is limited. Reports on the derivation of MSC-like cells from pluripotent stem cells (PSCs) are, thus, of interest, as the infinite prol… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

8
140
4

Year Published

2014
2014
2022
2022

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 134 publications
(152 citation statements)
references
References 56 publications
8
140
4
Order By: Relevance
“…Jin et al, directly induced iPSCs into osteoblastic lineage by culturing iPSCs on poly(caprolactone) scaffolds and adding exogenous osteogenic factors ascorbic acid, beta-glycerophosphate and dexamethasone [21]. Diederichs and Tuan derived MSC-like cells from iPSCs via four different derivation strategies: 1) EB formation, 2) spontaneous differentiation of iPS colonies, 3) mesenchymal co-culture system, and 4) indirect co-culture where iPSCs were seeded on top of cell-free extra cellular matrix from BMSCs and cultured with BMSC-conditioned medium [31]. All four methods succeeded in yielding iPSC-derived MSCs.…”
Section: Discussionmentioning
confidence: 99%
“…Jin et al, directly induced iPSCs into osteoblastic lineage by culturing iPSCs on poly(caprolactone) scaffolds and adding exogenous osteogenic factors ascorbic acid, beta-glycerophosphate and dexamethasone [21]. Diederichs and Tuan derived MSC-like cells from iPSCs via four different derivation strategies: 1) EB formation, 2) spontaneous differentiation of iPS colonies, 3) mesenchymal co-culture system, and 4) indirect co-culture where iPSCs were seeded on top of cell-free extra cellular matrix from BMSCs and cultured with BMSC-conditioned medium [31]. All four methods succeeded in yielding iPSC-derived MSCs.…”
Section: Discussionmentioning
confidence: 99%
“…Nevertheless, directed differentiation of iPSCs into a homogenous population of differentiated cells is technically difficult and can result in immature and/or inferior tissue with regards to cell and extra-cellular matrix organization [23]. Therefore, differentiating iPSCs into an intermediate multipotent cell type, such as MSCs, may not only reduce or eliminate the risk of teratoma formation upon implantation, but also to provide a more homogenous and mature cell type for tissue engineering [24]. Recently, successful differentiation of human and mouse iPSCs into MSC-like cells have been reported This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction.…”
Section: Introductionmentioning
confidence: 99%
“…The resulting cell cultures are enriched for MSCs through serial cell passaging [30] . Another version of this protocol relies on the spontaneous differentiation of pluripotent stem cells into MSCs [31] . Different research groups have developed additional steps to improve this method.…”
Section: Resultsmentioning
confidence: 99%
“…Interestingly, MSCs from mesoderm or from neuroectoderm origins can be derived depending on the stromal cells used [34,35] . Finally, MSCs derived from different hiPSC lines generated from different donors, or from the same hiPSC clone using different derivation approaches, have the same adipogenic features [30,31] . MSC adipogenic characteristics are therefore not dependent on the derivation method used.…”
Section: Resultsmentioning
confidence: 99%